A novel missense mutation of RYR1 in familial idiopathic hyper CK-emia

• Published in: Journal of the neurological sciences Vol. 356; no. 1; pp. 142 - 147
• Main Authors: Sano, Ken, Miura, Shiroh, Fujiwara, Toshiya, Fujioka, Ryuta, Yorita, Akiko, Noda, Kazuhito, Kida, Hiroshi, Azuma, Koichi, Kaieda, Shinjiro, Yamamoto, Ken, Taniwaki, Takayuki, Fukumaki, Yasuyuki, Shibata, Hiroki
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 15.09.2015
• Subjects: Animals; Autosomal dominant; Creatine kinase; Creatine Kinase - blood; DNA Mutational Analysis; Exome sequencing; Family Health; Female; Genetic Linkage; Humans; Hyper CK-emia; Japan; Male; Malignant hyperthermia; Metabolic Diseases - blood; Metabolic Diseases - genetics; Metabolic Diseases - metabolism; Metabolic Diseases - pathology; Muscle, Skeletal - enzymology; Muscle, Skeletal - pathology; Mutation, Missense - genetics; Neural Conduction - genetics; Neurology; Ryanodine receptor; Ryanodine Receptor Calcium Release Channel - genetics; Japan; Autosomal dominant; Malignant hyperthermia; Creatine kinase; Exome sequencing; Ryanodine receptor; Hyper CK-emia
• ISSN: 0022-510X; 1878-5883
• DOI: 10.1016/j.jns.2015.06.035

Abstract Persistent elevation of serum creatine kinase (CK) without any symptoms has been called idiopathic hyper CK-emia (IHCK). We examined a four-generation Japanese pedigree of familial IHCK. The multipoint linkage analysis of the pedigree showed seven clear peaks of logarithm of odds (LOD) scores (> 1.4). By the exome sequencing followed by multiple filtering processes, we identified one novel heterozygous nonsynonymous single nucleotide variant (SNV), c.7034G>C, p.S2345T in the ryanodine receptor 1 gene, RYR1 cosegregated with IHCK in the pedigree. Mutation Taster predicted this substitution as “disease causing” ( p = 0.999). The PolyPhen-2 and PANTHER subPSEC scores for the substitution are 0.911 (possibly damaging) and − 3.56 (probably damaging), respectively. We confirmed the absence of the SNV in 511 healthy Japanese individuals excluding the possibility of a normal variant with a very low frequency. Immunohistochemistry and Western blotting of biopsy samples consistently showed the expression level of RYR1 reduced in the patient. In real-time RT-PCR, the mRNA expression level of RYR1 was also significantly reduced in the patient ( p = 0.009). These results suggest that the novel nonsynonymous SNV contribute to the vulnerability of the RYR1 protein through the dominant negative effect. We conclude that the SNV in the RYR1 gene is one of the responsible genes of IHCK.